KATHERINE STADLER: Open Payments
NPI 1629578943 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,285 in 83 payments from 19 companies in 2025. Trend: 2023 $1,169 · 2024 $1,285 · 2025 $1,285
Food & beverage: $1,285
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 35 | $332 |
| Mannkind Corporation | 6 | $128 |
| Lilly USA, LLC | 6 | $115 |
| Dexcom, Inc. | 5 | $111 |
| Novo Nordisk Inc | 5 | $99 |
| Tandem Diabetes Care, Inc. | 4 | $82 |
| Ascendis Pharma Endocrinology Inc | 2 | $59 |
| Amgen Inc. | 4 | $56 |
| ABBVIE INC. | 3 | $49 |
| Antares Pharma, Inc. | 2 | $38 |
Products named: Omnipod, AFREZZA, Dexcom G6 Transmitter, MOUNJARO, t:slim X2 Insulin Pump with Control-IQ, Yorvipath, EVENITY, Ozempic.
Industry payments across KS — which companies pay providers there.
